Clinical Trial

Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This is a randomized, active-controlled, observer-blinded, dose-escalation multi-center trial of 2 doses of an investigational HZ vaccine (Z-1018) in approximately 764 healthy adults.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-22; most recent amendment 2026-05-27.
Status change: Recruiting → Active, Not Recruiting 2026-05-27
Trial Details
NCT Number NCT06569823
Lead Sponsor Dynavax Technologies Corporation
Conditions Shingles, Herpes Zoster, Vaccine-Preventable Diseases
Enrollment 764 participants
Start Date 2024-06-17
Primary Completion 2027-11 (estimated)
Study Completion 2031-11 (estimated)
Updated on ClinicalTrials.gov 2026-05-29